Cagrilintide 5 mg

Specification

Amylin receptor pathway

Cagrilintide is a synthetic, lipidated amylin analogue. Amylin is released with insulin from pancreatic beta cells and binds receptor complexes of the calcitonin receptor (CTR) and receptor activity-modifying proteins (RAMPs). Cagrilintide reproduces this binding, with a longer residence time from lipidation. In research the molecule is a defined agonist for amylin-mediated cAMP signals, receptor internalization, and downstream effects in neuronal and endocrine cell lines. Laboratories that buy Cagrilintide obtain the amylin analogue at 5 mg per vial in the 10-vial box.

Satiety and energy balance

The amylin pathway links central and peripheral control of food intake: slower gastric emptying, satiety signals in the brainstem, and modulation of energy balance. Cagrilintide is used in preclinical weight-management models and in vitro to test this axis as its own route. Combination designs with GLP-1 or GIP reference ligands examine additive effects on food intake and body weight in animal cohorts. The peptide is a reproducible component for metabolic programs on adiposity and energy homeostasis.

Reconstitution and handling

The lyophilizate is reconstituted in the laboratory with a suitable sterile solvent. Solvent is added slowly along the vessel wall, and the preparation is swirled gently until the powder has fully dissolved. A slow swirl keeps the lipidated peptide evenly in solution. The solution is then processed promptly. Until use, the reagent is kept out of direct light. The performing laboratory sets concentration and aliquot size in its own protocol.

Laboratory assays and models

In competitive binding studies, researchers measure the affinity of Cagrilintide at the AMY1, AMY2, and AMY3 receptor complexes. cAMP reporter assays and calcium imaging record agonist activity in transfected cell lines. In ex vivo samples from hypothalamus or the gastrointestinal tract, local amylin responses can be measured. After a standard reconstitution, the soluble lyophilizate suits dilution series and concentration-response curves. Parallel runs with native amylin or other analogue references support direct ligand comparison within one study.

Quality and analytics

Each batch of Cagrilintide is assayed for purity by HPLC, and the result is ≥99 %. An identity test confirms the lipidated amylin analogue. Findings are recorded for each batch. This analytical record supports reproducible binding and signal assays in programs on satiety, food intake, and weight regulation.